BIIB logo

BIIB

Biogen Inc.

$177.96
-$1.13(-0.63%)
64
Overall
80
Value
72
Tech
42
Quality
Market Cap
$26.47B
Volume
936.43K
52W Range
$110.04 - $190.20
Target Price
$190.32

Latest News for BIIB

The Week That Was, The Week Ahead: Macro and Markets, Feb. 1
Ran Melamed2 days agoFeb 01, 2026

U.S. stocks ended the week lower as pressure from rates and commodities weighed on risk appetite. The Dow Jones Industrial Average (DJIA) fell 0.36......

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Teleflex (TFX) and Biogen (BIIB)
Christine Brown13 days agoJan 22, 2026

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Teleflex (TFX – Research Report) and Biogen (BIIB ......

Wells Fargo Reaffirms Their Hold Rating on Biogen (BIIB)
TipRanks Auto-Generated Intelligence Newsdesk13 days agoJan 21, 2026

In a report released today, from Wells Fargo maintained a Hold rating on Biogen, with a price target of $190.00. In addition to Wells Fargo, Biogen......

Jefferies Keeps Their Buy Rating on Biogen (BIIB)
TipRanks Auto-Generated Intelligence Newsdesk20 days agoJan 14, 2026

Jefferies analyst Andrew Tsai maintained a Buy rating on Biogen today and set a price target of $210.00. Tsai covers the Healthcare sector, focusin......

Biogen Advances Presymptomatic SMA Strategy With New Salanersen Trial
TipRanks Clinical-Trials-Auto-Generated Newsdesk22 days agoJan 12, 2026

Biogen Inc. ($BIIB) announced an update on their ongoing clinical study. Study OverviewThis Phase 3 Biogen study, officially titled “An Open-Label ......

Biogen Advances New SKYCLARYS Formulation in Early Trial, Supporting Long-Term Rare Disease Strategy
TipRanks Clinical-Trials-Auto-Generated Newsdesk25 days agoJan 09, 2026

Biogen Inc. ($BIIB) announced an update on their ongoing clinical study. Study OverviewThis Phase 1 Biogen study, officially titled “A Phase 1, Ran......

Biogen (BIIB) Gets a Hold from Piper Sandler
TipRanks Auto-Generated Intelligence Newsdeska month agoJan 07, 2026

Piper Sandler analyst David Amsellem reiterated a Hold rating on Biogen today and set a price target of $157.00. Amsellem covers the Healthcare sec......

Wall Street Analysts Are Bullish on Top Healthcare Picks
Brian Andersona month agoJan 06, 2026

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on LENZ Therapeutics (LENZ – Research Report) and Bioge......

Biogen (BIIB) Receives a Hold from Bank of America Securities
TipRanks Auto-Generated Intelligence Newsdeska month agoJan 05, 2026

In a report released today, Tim Anderson from Bank of America Securities reiterated a Hold rating on Biogen, with a price target of $189.00. Accord......

News data is sourced from MarketXLS API and updated regularly.
Showing 9 of 9 articles.

ABCD
1SymbolPriceChangeVol
2BIIB$177.96-0.6%936.43K
3
4
5
6

Get Biogen Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.